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Background: The present study was designed to evaluate the effects of the aqueous extract obtained from the
mixture of fresh leaf of Persea americana, stems and fresh leaf of Cymbopogon citratus, fruits of Citrus medica and
honey on ethanol and sucrose induced hypertension in rats.
Methods: Rats were divided into eight groups of 6 rats each and daily treated for 5 weeks. The control group
received distilled water (1 mL/kg) while rats of groups 2, 3 and 4 received ethanol 40 degrees (3 g/kg/day), 10%
sucrose as drinking water and the two substances respectively. The remaining groups received in addition to
sucrose and ethanol, the aqueous extract (50, 100 and 150 mg/kg) or nifedipine (10 mg/kg) respectively. Many
parameters including hemodynamic, biochemical and histopathological were assessed at the end of the study.
Results: The concomitant consumption of ethanol and sucrose significantly (p < 0.001) increased the blood
pressure and the heart rate compared to distilled water treated-rats. The levels of total cholesterol, LDL-cholesterol,
triglycerides, atherogenic index, glucose, proteins, AST, ALT, creatinin, potassium, sodium and albumin increased
while the HDL-cholesterol decreased under ethanol and sucrose feeding. Chronic ethanol and sucrose intake
significantly decreased the activities of superoxide dismutase (SOD) and catalase (CAT) as well as the contents of
reduced glutathione (GSH) and nitrites whereas elevated the malondialdehyde (MDA) levels. Histological analysis
revealed among other vascular congestion, inflammation, tubular clarification and thickening of the vessel wall in rats
treated with alcohol and sucrose. Administration of the aqueous extract or nifedipine prevented the hemodynamic,
biochemical, oxidative and histological impairments induced chronic ethanol and sucrose consumption.
Conclusion: Current results suggest that the aqueous extract used in this study possess antihypertensive activity
against ethanol and sucrose induced hypertension in rats by the improvement of biochemical and oxidative status,
and by protecting liver, kidney and vascular endothelium against damages induced by chronic consumption of
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Hypertension is currently one of the major risk factors
for cardiovascular, neurological and renal events. Several
studies demonstrated that excessive and chronic ingestion
of ethanol causes cardiomyopathy, cardiac arrhythmias,
heart failure and hypertension [1-3]. Similarly, numerous
studies also indicate that diets high in carbohydrates,
particularly sugars and even more particularly sucrose
and fructose increase the risk of cardiovascular diseases
including hypertension [4]. It has been reported that some
metabolic abnormalities such as hyperinsulinemia, insulin
resistance and hypertriglyceridemia as well as hyperactiv-
ity of the sympathetic nervous system and oxidative stress
were frequently associated with the pathogenesis of both
ethanol and sucrose induced-hypertension [5]. It is well
known that hypertension can often lead to lethal compli-
cations if left untreated [6].
In spite of the large number of modern drugs, people
largely use complementary and alternative medicine to
prevent and cure illness [7] for curiosity and also the idea
that combining it with conventional treatment would help
[8]. A holistic or a spiritual health view and the belief that
herbs are natural (and thus safe) also seem to be associate
with the use of alternative medicine [9]. Traditionally, many
of the folk remedies of plant origin have long been used
for the treatment of various ailments, usually as mixture
of many plants in combination with honey, palm oil or
limestone [10]. Therefore, there is an urgent need to de-
velop new and effective drugs for the treatment of hy-
pertension. In this view, medicinal plants such as Persea
Americana, Cymbopogon citratus and Citrus medica mixt
with honey are known to have many and various metabo-
lites possessing potential for the prevention and treatment
of several diseases. Persea americana (avocado) is a tree
belonging to the Lauraceae family which is used in trad-
itional medicine for the treatment of ailments such as
stomach ache, bronchitis, diarrhoea, diabetes and hyper-
tension [11]. Additively, the cardioprotective effects of
Persea americana have been widely demonstrated [12] as
well as its lipid-lowering [13] and hypoglycemic effects
[14]. Cymbopogon citratus commonly known as lemon
grass is a widely used herb belonging to the Poaceae fam-
ily. Phytochemical and pharmacological analysis of this
plant revealed the presence of compound such as citral
which acts as a calcium antagonist [15]. The plant is
also known to exhibit antioxidant, anti-inflammatory,
hypoglycemic, antimicrobial and chemoprotective effects
[16]. Furthermore, Cymbopogon citratus is popularly
used as antispasmodic, antipyretic, sedative, diuretic
and hypotensive [17]. Citrus medica also called lemon
is a plant belonging to the Rutaceae family. Lemons
contain significant amounts of citric acid; this is why
they have a low pH and a sour taste. They also contain
vitamin C (ascorbic acid) which is essential to humanhealth. These phytochemical constituents of lemon in-
hibit the synthesis and activity of mediators involved
in inflammation such as derivatives of arachidonic acid,
prostaglandins E2, F2 and thromboxane A2 [18]. The main
flavonoids in the lemon are eriocitrine and hesperetin. Ex-
periments on animals have shown that these phytochem-
ical constituents could reduce or prevent damages related
to oxidative stress [19]. Lemon through its high pectin
levels is also able to dissolve fat and to lower blood choles-
terol levels [20]. Honey is a natural source of energy with
a relatively low glycaemic index [21]. In addition to be a
source of energy, honey is an important source of antioxi-
dants including flavonoids and phenolic compounds very
effective to scavenge free radicals. These active principles
contribute to reduce the risk of cardiovascular diseases
and some cancers [22]. Honey is used to stimulate cell
renewal (scarring), to fight tiredness and stress, to boost
the immune system and possess anti-inflammatory and
antibiotic activities [21]. Honey consumption also reduces
the effects of ethanol [23].
Information provided by practitioners of traditional
medicine in West Region of Cameroon indicates that the
mixture of the fresh leaf of Persea americana, stems and
fresh leaf of Cymbopogon citratus, fruits of Citrus medica
and honey is used to treat hypertension. Therefore, the
present study was undertaken to evaluate the effects of
the aqueous extract resulting from that mixture on etha-
nol and sucrose induced hypertension in rats.
Methods
Animals
The antihypertensive activity of the extract was carried
out on 48 males albino Wistar rats aged 6-8 weeks and
weighting 150-160 g prior to the experiment. Animals
were housed in standard environmental conditions under
a 12/12 h light/dark natural cycle in the animal house of
the Laboratory of Animal Physiology of the University of
Yaounde I. All animals had free access to standard diet
and tap water ad libitum.
Preparation of aqueous extract
The aqueous extract was prepared from the mixture con-
sisted of fresh leaf of Persea Americana (70 g), fresh leaf
and stems of Cymbopogon citratus (110 g), fruits of Citrus
medica (300 g) and honey (500 g). These biological mate-
rials were harvested in Bandjoun in the West Region of
Cameroon in March 2012 and identified at the National
Herbarium by comparison to the voucher specimen N°
57756 NHC for Persea Americana, N° 16628/SFR/Cam
for Cymbopogon citratus and N° 65106/HNC for Citrus
medica. The mixture mentioned above was boiled in
2.5 L of distilled water for 40 minutes. The resulting
crude aqueous extract was filtered using a filter paper
(Whatmann N° 3) followed by evaporation at 40°C using
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was 24.31%.
Ethical consideration
All animal treatment procedures used in the present
study were approved by the Cameroon National Ethical
Committee (Ref. N° FWIRB 00001954).
Experimental design
The antihypertensive activity of the aqueous extract was
evaluated by using ethanol and sucrose induced hyper-
tension in rats as previously described [2]. Rats were ran-
domly divided in eight groups of six rats each and daily
treated for five consecutive weeks.
Animals of the first group (control) received by oral
gavage distilled water (1 mL/kg/day). Rats of group 2 were
treated by oral gavage with ethanol 40° (3 g/kg/day), group
3 received sucrose 10% as drinking water and group 4
received simultaneously ethanol 40° and sucrose 10%. Rats
of groups 5-8 received by oral gavage in addition to
ethanol and sucrose, the aqueous extract (50, 100 and
150 mg/kg) or the calcium inhibitor, nifedipine (10 mg/kg)
respectively. During the experimental period, the body
weight was assessed twice a week. At the end of the investi-
gation period, blood pressure and heart rate of all rats were
measured according to the method previously described
[2]. Briefly, each rat was anesthetized using an intraperito-
neal injection of urethane (1.5 g/kg). The trachea was ex-
posed and cannulated to facilitate spontaneous breathing.
The arterial blood pressure and heart rate were measured
from right carotid artery via an arterial cannula connected
to a pressure transducer coupled with a hemodynamic
recorder Biopac Student Lab. (MP35) and computer. Thirty
minutes of equilibration period were observed before each
measure. Changes in mean arterial pressure were calcu-
lated using the equation below:
Mean arterial pressure ¼ 1=3ðsystolic arterial pressure
þ 2 diastolic arterial pressureÞ:
Biochemical and histological analysis
After recording hemodynamic parameters, rats were
sacrificed and the free running blood was collected and
centrifuged at 3000 rpm for 15 minutes. The serum ob-
tained was stored at -20°C for the determination of some
biochemical markers. Serum samples were assayed for tri-
glycerides, total cholesterol, HDL-cholesterol, albumin,
creatinin, alanine aminotransferase (ALT) and aspartate
aminotransferase (AST) using the commercial diagnostic
kit Fortress. The atherogenic index (AI) was calculated by
the following formula: AI = ([total cholesterol] – [HDL-
cholesterol)])/ [HDL-cholesterol)] [24]. The glucose assaywas performed using the kit Inmesco while sodium ions
were quantified using the Atlas Medical kit.
After blood collection, organs (aorta, liver and kidney)
of each animal were dissected out and part of each organ
was homogenized. Aorta was homogenized in 10 volumes
of Mc Even solution whereas liver and kidney were homo-
genized in 5 volumes of 50 mM Tris-HCl. The homo-
genate (20% for aorta and 10% for the other organs) were
centrifuged at 3000 rpm for 15 minutes at 4°C. The
supernatant collected was stored at -20°C for further
biochemical studies. The total protein was performed by
the method of Gornall et al. [25] and the activity of su-
peroxide dismutase (SOD) was assessed according to the
protocol described by Misra and Fridovish [26]. Reduced
glutathione (GSH) and catalase were assayed following the
method described by Ellman [27] and Sinha [28] respect-
ively. Nitrites content was estimated using the protocol of
Slack [29] while the concentration of malondialdehyde
was determined by the method described by Wilbur et al.
[30]. For microscopic evaluation, part of investigated or-
gans was fixed in 10% formalin for 7 days and paraffin em-
bedded for microscopical examination in accordance with
routine laboratory procedure. Paraffin sections of 4 μm
were prepared and stained with haematoxylin and eosin
(H&E) and Masson Trichrome for histological examin-
ation. Morphometric measurements of the thickness
of arteries were performed using the axio HOME system
(Carl Zeiss, Oberkochen, Germany). Briefly, the system
consists of an IBM-PC compatible computer using the
2.04 version of the Zeiss-Alcatel TITN Answare software
(Meylan, France) and an in-built light microscope. Six
arteries per animal were quantified, given a total of 36 ves-
sels per group.
Statistical analysis
Statistical analysis was performed using SPSS 16.0. All data
were analysed by one-way analysis of variance (ANOVA)
followed by the Tukey post hoc test and expressed as
mean ± standard error of the mean (SEM). The difference
was considered significant at p < 0.05.
Results
Effects of the extract on body weight, blood pressure and
heart rate
Changes in body weight of the control and treated rats
are presented in Table 1. Rats gained weight during the
experimental period with no significant difference in
weight gain at the end of the study between controls and
rats treated with the aqueous extract at the doses of 50,
100 and 150 mg/kg.
Variations in systolic arterial blood pressure (SAP), mean
arterial blood pressure (MAP), diastolic arterial blood pres-
sure (DAP) and heart rate (HR) are presented in Table 1.
Chronic consumption of ethanol 40° (3 g/kg/day) and/or
Table 1 Effects of the extract on body weight gain, blood pressure and heart rate
Body weight gain (g) DAP (mm Hg) MAP (mm Hg) SAP (mm Hg) HR (BPM)
Water 76.20 ± 1.98 76.92 ± 1.40 90.46 ± 1.29 117.50 ± 1.27 352.60 ± 3.77
Ethanol 79.95 ± 3.68 96.90 ± 1.38aα 114.50 ± 1.67aα 149.70 ± 2.46aα 398.40 ± 2.06aα
Sucrose 59.17 ± 1.91 98.48 ± 1 .40aα 116.50 ± 1.78aα 152.72 ± 2.67aα 392.00 ± 3.52aα
EtOH+ Su 52.02 ± 1.79 109.08 ± 1.29a 129.70 ± 0.99a 171.12 ± 2.71 a 423.80 ± 2.37a
EtOH + Su + Nif 51.42 ± 2.31 90.68 ± 1.54aα 106.00 ± 1.41aα 136.70 ± 1.37aα 372.60 ± 2.30aα
EtOH + Su + Ext50 67.57 ± 2.62 80.92 ± 1.36α 94.44 ± 1.39α 121.48 ± 1.66α 360.80 ± 1.95α
EtOH + Su + Ext100 59.40 ± 2.03 77.50 ± 1.14α 89.84 ± 1.05α 114.54 ± 1.9α 350.60 ± 1.88α
EtOH + Su + Ext150 60.02 ± 1.53 76.94 ± 1.55α 88.81 ± 1.52α 112.56 ± 1.74α 352.80 ± 3.01α
Each value represents a mean ± S.E.M.; n = 5; ap < 0.001: significantly different compared to water. αp < 0.001: significantly different compared to ethanol and
sucrose. DAP = diastolic arterial blood pressure, MAP =mean arterial blood pressure, SAP = systolic arterial blood pressure, HR = heart rate, EtOH + Su = Ethanol and
Sucrose; Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/kg; Nif = Nifedipine (10 mg/kg).
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arterial blood pressure and heart rate as compared with
rats receiving distilled water. The increase of MAP and
HR was by 25.97% and 12.98% in ethanol-treated group,
by 28.02% and 11.17% in sucrose-fed group and by 41.80%
and 22.74% in group receiving simultaneously the two
substances. The increase of blood pressure and heart rate
induced by ethanol and sucrose consumption was signifi-
cantly (p <0.001) prevented in groups that received add-
itionally the aqueous extract or nifedipine. The MAP and
HR of rats that were orally administered the extract were
lowered respectively by 16.86% and 4.94% at 50 mg/kg,
by 25.81% and 7.95% at 100 mg/kg and by 28.95% and
10.56% at 150 mg/kg compared to ethanol and sucrose
treated group. Similarly, the administration of nifedipine
(10 mg/kg) decreased by 29.46% and 10.00% the MAP
and HR respectively compared with the group submitted
to ethanol and sucrose.
Effects of the extract on some serum biochemical
parameters
Effects on lipid profile and glucose content
As shown in Table 2, the daily ingestion of ethanol 40°
(3 g/kg) or sucrose (10%) ad libitum for 5 consecutiveTable 2 Effect of the extract on blood glucose and lipid profi
Glucose (mg/dL) Triglycerides (mg/dL) Total c
Water 110.60 ± 10.65 152.38 ± 9.98
Ethanol 152.50 ± 13.29c 213.33 ± 7.33aα
Sucrose 165.95 ± 8.23c 221.58 ± 4.53aβ 2
EtOH+ Su 153.31 ± 10.42c 257.14 ± 2.24a 2
EtOH + Su + Nif 113.76 ± 13.25 51.42 ± 5.25aα 1
EtOH + Su + Ext50 126.27 ± 13.47 90.79 ± 4.77aα
EtOH + Su + Ext100 101.48 ± 8.53γ 68.57 ± 4.77aα 1
EtOH + Su + Ext150 110.11 ± 9.59γ 51.42 ± 3.38aα
Each value represents a mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01, cp < 0.05: significa
different compared to ethanol and sucrose. EtOH + Su = Ethanol and Sucrose; Ext50
150 mg/kg; Nif = Nifedipine.weeks significantly increased by 34.43% and 42.30% the
total cholesterol, by 40.00% and 45.41% the content of
triglycerides and by 52.39% and 56.18% the atherogenic
index while the HDL-cholesterol decreased by 38.66% and
40.11% respectively compared to normal control group. In
group treated simultaneously with ethanol and sucrose,
the significant increase of the level of total cholesterol, tri-
glycerides and atherogenic index was respectively 49.84%,
68.75% and 65.30% whereas the HDL-cholesterol decrease
was 50.96% compared to distilled water-treated rats. Treat-
ment with the aqueous extract (50, 100 and 150 mg/kg) in
combination with ethanol and sucrose prevented the vari-
ation of serum total cholesterol, triglycerides, atherogenic
index and HDL-cholesterol as compared to the ethanol-
sucrose-treated group. At the higher dose (150 mg/kg), the
aqueous extract significantly reduced the total cholesterol
by 42.23%, triglycerides by 80.00% and the atherogenic
index by 44.49% meanwhile the HDL-cholesterol increased
by 89.01% when compared to ethanol and sucrose treated
group. Nifedipine (10 mg/kg) administered in addition to
ethanol and sucrose significantly improved lipid profile as
compared to untreated-rats.
The serum level of glucose was 110.60 ± 10.65 mg/dL
in normal control group (Table 2). The value of thisle
holesterol (mg/dL) HDL–cholesterol (mg/dL) Atherogenic index
156.41 ± 8.61 74.49 ± 5.43 0.51 ± 0.07
210.25 ± 15.74 45.68 ± 4.40a 0.78 ± 0.03b
22.56 ± 17.16c 44.61 ± 4.31a 0.80 ± 0.02b
34.35 ± 15.16b 36.52 ± 3.18a 0.84 ± 0.01a
53.84 ± 6.01 β 70.59 ± 4.61α 0.54 ± 0.04α
185.12 ± 14.80 47.00 ± 3.57b 0.74 ± 0.01b
45.12 ± 14.47β 55.38 ± 3.00γ 0.61 ± 0.02γ
135.38 ± 9.84α 69.04 ± 3.94α 0.47 ± 0.08α
ntly different compared to water. αp < 0.001, βp < 0.01, γp < 0.05: significantly
, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and
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by 37.87% in ethanol-treated group, by 50.04% in sucrose-
fed group and by 38.61% in ethanol-sucrose-fed group
compared to distilled water-treated group. However, in
group treated with the aqueous extract in addition to
ethanol and sucrose, the serum glucose level signifi-
cantly (p <0.05) decreased by 33.80% at 100 mg/kg and by
28.18% at 150 mg/kg compared to untreated rats. In the
same condition, nifedipine (10 mg/kg) lowered by 25.79%
the serum glucose content compared to rats simultan-
eously treated with ethanol and sucrose.
Effects on some parameters of the liver and kidney functions
Repeated oral ingestion of ethanol, sucrose or the two
ingredients for 5 weeks increased by 59.00%, 72.80% and
85.86% the serum total protein and by 30.02%, 33.85%
and 29.06% the albumin content (Table 3). Furthermore,
chronic ethanol and/or sucrose feeding promoted signi-
ficant increase in AST and ALT activities compared to
control group. In ethanol-sucrose treated group, AST
and ALT activities increased by 111.81% and 96.20%
respectively compared to distilled water-treated group.
However, the administration of the aqueous extract (50,
100 and 150 mg/kg) or nifedipine (10 mg/kg) in asso-
ciation with simultaneous ethanol and sucrose intake
resulted in a significant decrease in serum total proteins,
albumin, AST and ALT when compared to ethanol-sucrose
untreated rats. At the dose of 150 mg/kg, the extract sig-
nificantly (p < 0.001) lowered by 85.25% the total proteins
content and by 50.64% and 56.12% the activity of AST and
ALT respectively compared with ethanol-sucrose-treated
group.
As summarized in Table 3, chronic ethanol and/or
sucrose consumption affected the kidney function in the
current study by increasing significantly serum creatinin,
potassium and sodium levels compared to control rats
treated with distilled water. In group receiving simultan-







Water 26.77 ± 3.84 70.96 ± 10.20 23.53 ± 1.51
Ethanol 46.44 ± 5.24 116.12 ± 16.69 37.42 ± 5.17c
Sucrose 45.42 ± 5.65 130.96 ± 11.65c 40.66 ± 1.64b
EtOH+ Su 52.54 ± 4.79c 150.32 ± 11.10a 43.74 ± 4.21a
EtOH + Su + Nif 22.71 ± 3.15β 65.16 ± 7.59α 5.72 ± 1.02bα
EtOH + Su + Ext50 34.91 ± 6.72 115.48 ± 10.06 16.81 ± 2.52α
EtOH + Su + Ext100 27.79 ± 3.28γ 92.25 ± 12.60γ 6.73 ± 1.25bα
EtOH + Su + Ext150 23.05 ± 3.65β 74.19 ± 12.45β 6.45 ± 0.67bα
Each value represents a mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01, cp < 0.05: significa
different compared to ethanol and sucrose. EtOH + Su = Ethanol and Sucrose; Ext50
kg; Nif = Nifedipine (10 mg/kg).period, the increase in the content of these kidney markers
was 182.45% (p < 0.001) for creatinin, 65.64% (p < 0.01)
for potassium and 21.69% (p < 0.05) for sodium. As com-
pared to ethanol-sucrose treated group, the aqueous
extract (100 and 150 mg/kg) reduced the serum crea-
tinin by 27.95% (p < 0.05) and 50.93% (p < 0.001), potas-
sium by 28.33% (p < 0.05) and 45.38% (p <0.01) and
sodium by 25.89% (p <0.05) and 29.25% (p < 0.05) respect-
ively. Nifedipine administered in the same condition sig-
nificantly prevented the rise in serum creatinin, potassium
and sodium levels induced by ethanol and sucrose.
Effects of the extract on some parameters of oxidative
stress
Effects of the extract on total protein
As shown in Figure 1, the total protein content in the
liver was increased by 112.25% (p < 0.05) in group treated
with sucrose (10%) and by 74.83% (p < 0.05) in ethanol
and sucrose administered rats as compared with control.
The association of the extract or nifedipine in the treatment
of rats submitted to the ingestion of ethanol and sucrose
induced a reduction of total protein in all investigated tis-
sues as compared with untreated rats.
Effects of the extract on reduced glutathione content
Figure 2 shows the concentration of reduced glutathione
(GSH) in tissues of normal and experimental groups.
GSH content was found to be decreased in ethanol and/or
sucrose fed-animals in comparison with distilled-water
treated rats. The decrease of this parameter in rats treated
simultaneously with ethanol and sucrose was 53.49%
(p < 0.05) in aorta, 58.63% (p < 0.001) in heart, 64.46%
(p < 0.001) in liver and 50.24% (p < 0.01) in kidney as com-
pared to normal control value. Oral administration of the
aqueous extract or nifedipine significantly restored the
amount of GSH in both rat tissues when compared to
ethanol-sucrose-treated group. The increase in the con-









26.08 ± 2.52 0.38 ± 0.06 6.30 ± 0.79 136.41 ± 5.51
33.91 ± 3.41 0.96 ± 0.07a 9.89 ± 0.93 169.80 ± 7.32
34.91 ± 3.18 0.90 ± 0.03a 9.43 ± 0.99 149.80 ± 10.49
33.66 ± 3.88 1.07 ± 0.04a 10.44 ± 0.71c 166.01 ± 7.99
23.24 ± 1.88 0.48 ± 0.05α 5.10 ± 0.76α 122.08 ± 10.75γ
32.29 ± 1.70 0.83 ± 0.06a 9.26 ± 0.56 139.00 ± 9.49
28.26 ± 1.67 0.77 ± 0.06bγ 7.48 ± 0.81γ 123.03 ± 10.82γ
26.24 ± 1.02 0.52 ± 0.06α 5.70 ± 0.96β 117.46 ± 10.80γ
ntly different compared to water. αp < 0.001, βp < 0.01, γp < 0.05: significantly
, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/
Figure 1 Effect of the extract on tissue proteins. Each bar represents a mean ± S.E.M.; n = 5; ap < 0.001, cp < 0.05: significantly different
compared to water. βp < 0.01, γp < 0.05: significantly different compared to ethanol and sucrose. EtOH + Su = Ethanol and Sucrose; Ext50, Ext100
and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/kg; Nif = Nifedipine.
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170.94% (p < 0.001) in heart, 283.04% (p < 0.001) in liver
and 157.91% (p < 0.001) in kidney.
Effects of the extract on superoxide dismutase and catalase
activities
The activities of antioxidant enzymes superoxide dismut-
ase (SOD) and catalase in homogenates tissues of control
and experimental rats are illustrated by Figures 3 and 4.
A significant depletion of SOD activity in liver and heart
were observed following ethanol and/or sucrose treat-
ment. In group simultaneously treated with ethanol and
sucrose, the activity of SOD was lowered by 35.84%
(p < 0.05) in aorta, by 69.81% (p < 0.001) in liver and by
68.36% (p < 0.01) in kidney compared with normal control
rats. Interestingly, the activity of catalase was significantly
decreased only in the liver when rats were treated eitherFigure 2 Effect of the extract on reduced glutathione levels. Each bar
significantly different compared to water. αp < 0.001, βp < 0.01, γp < 0.05 : sign
and Sucrose; Ext50, Ext100 and Ext150 = Extract at the respective doses of 50,with ethanol or sucrose, but in group receiving both
substances, this activity was found to be significantly re-
duced in all tested tissues. Oral administration of the
extract (100 and 150 mg/kg) exhibited significant increase
in the activity of the enzymatic markers of oxidative status
mentioned above compared with ethanol-sucrose un-
treated group. At the dose of 150 mg/kg, the extract im-
proved respectively the activity of catalase and SOD
by 238.98% (p < 0.001) and 167.87% (p < 0.001) in aorta,
by 559.25% (p < 0.001) and 61.07% (p > 0.05) in heart, by
387.27% (p < 0.001) and 264.46% (p < 0.001) in liver and
by 314.81% (p < 0.001) and 282.90% (p < 0.001) in kidney
compared with untreated group.
Effects of the extract on malondialdehyde content
Figure 5 shows that ethanol and sucrose alone or to-
gether significantly (p < 0.01) increased the level of therepresents a mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01, cp < 0.05:
ificantly different compared to ethanol and sucrose. EtOH + Su = Ethanol
100 and 150 mg/kg; Nif = Nifedipine.
Figure 3 Effects of the extract on the activities of superoxide dismutase. Each bar represents a mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01,
cp < 0.05 : significantly different compared to water. αp < 0.001, βp < 0.01, γp < 0.05: significantly different compared to Ethanol and sucrose.
EtOH + Su = Ethanol and Sucrose; Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/kg; Nif = Nifedipine.
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(MDA) in various investigated tissues when compared
with normal control rats. The MDA content increased
by 247.20% in aorta, by 184.05% in heart, by 294.79% in
liver and by 105.41% in kidney in ethanol-sucrose ingested
rats as compared with distilled water-fed group. Treatment
with the doses of 50, 100 and 150 mg/kg of the aqueous
extract as well as nifedipine (10 mg/kg) significantly
(p < 0.001) prevented the increase of MDA as compared
to ethanol-sucrose-administered rats.
Effects of the extract on nitrites content
Figure 6 represents the level of nitrites in aorta, heart, liver
and kidney of different rat groups. Results of this study
clearly revealed that ethanol and sucrose intake alone
or together decrease the concentration of nitrites in the
above tissues compared with normal control group. AsFigure 4 Effects of the extract on the activities of catalase. Each bar re
different compared to water. αp < 0.001, γp < 0.05: significantly different com
Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 1compared to distilled water-fed rats, nitrites content in
group daily treated with ethanol and sucrose declined by
76.98% (p < 0.001) in aorta, by 59.39% (p < 0.01) in heart,
by 60.21% (p < 0.01) in liver and by 56.79% (p < 0.001) in
kidney. Treatment with the aqueous extract (100 and
150 mg/kg) as well as nifedipine (10 mg/kg) prevented the
decline of nitrites content compared to ethanol-sucrose
untreated rats. The level of nitrites in rats treated with the
extract (100 mg/kg) was increased by 349.09% (p < 0.001)
in aorta, by 130.84% (p < 0.05) in heart, by 64.00%
(p > 0.05) in liver and by 81.14% (p < 0.01) in kidney when
compared with ethanol and sucrose untreated group.
Effects of the extract on some histological parameters
Hematoxylin and eosin stained section showed normal
aspect in the morphology of aorta, liver and kidney of
control group treated with distilled water (Figure 7). Thepresents a mean ± S.E.M.; n = 5; bp < 0.01, cp < 0.05: significantly
pared to ethanol and sucrose. EtOH + Su = Ethanol and Sucrose;
50 mg/kg; Nif = Nifedipine.
Figure 5 Effects of the extract on malondialdehyde content. Each bar represents a mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01, cp < 0.05:
significantly different compared to water. αp < 0.001, βp < 0.01, γp < 0.05: significantly different compared to ethanol and sucrose. EtOH + Su = Ethanol
and Sucrose; Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/kg; Nif = Nifedipine.
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produced vascular congestion, hepatocytes degeneration
and dilatation of sinusoids capillaries in the liver. Similarly,
ethanol and sucrose induced tubular clarifications in the
kidney and thickness in the arterial walls leading to the
reduction in the blood vessel diameter. The thickness of
the aorta of ethanol-sucrose untreated rats (376.31 ±
15.31 μm) significantly (p < 0.001) increased by 159.31%
when compared to normal rats. The aqueous extract
(100 and 150 mg/kg) prevented the morphological mo-
difications induced by ethanol and sucrose in in-
vestigated organs. As compared to untreated rats, the
thickness of aorta in rats treated with the extract (100 and
150 mg/kg) was reduced (p < 0.001) by 36.45 and 60.05%
respectively.Figure 6 Effects of the extract on nitrites content. Each bar represents
different compared to water. αp < 0.001, βp < 0.01: significantly different com
Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 1Discussion
In the present study, ethanol-sucrose induced hyperten-
sion was used to assess the antihypertensive effects of the
aqueous extract obtained from the mixture of fresh leaf of
Persea americana, stems and fresh leaf of Cymbopogon
citratus, fruits of Citrus medica and honey. Results ob-
tained showed that chronic high consumption of ethanol
and/or sucrose increase blood pressure and heart rate.
These findings are in agreement with previous studies
demonstrating that ethanol and/or sucrose can cause hy-
pertension, one component of a multifacetal metabolic-
hemodynamic complex that also includes dyslipidemia,
enhanced vascular resistance and oxidative stress [2,3].
Results disclose that the aqueous extract is efficient as an-
tihypertensive agent by significantly and dose-dependentlya mean ± S.E.M.; n = 5; ap < 0.001; bp < 0.01, cp < 0.05: significantly
pared to ethanol and sucrose. EtOH + Su = Ethanol and Sucrose;
50 mg/kg; Nif = Nifedipine.




























Figure 7 Micro photography of aorta liver and kidney. Haematoxylin/Eosine and Masson Trichrome staining; X400; n = 36 for aorta;
EtOH + Su = Ethanol and Sucrose; Ext50, Ext100 and Ext150 = Extract at the respective doses of 50, 100 and 150 mg/kg. A: Adventice; I: Intima;
M: Media; CV: Vascular Congestion; GL: Glomeruli; TC: Tubular Clarification; HD: hepatocytes Degeneration; US: urinary space; T: Tubules.
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in ethanol-sucrose hypertensive rats. Indeed, various find-
ings have shown the presence of phytocompounds such as
flavonoids, alkaloids, tannin and phenolic compounds in
the different medicinal plants and honey used to prepare
the aqueous extract [11,19,22,31]. The antihypertensive
effects of this extract may be due to the presence of the
above phytochemical components which are known for
their vasorelexant and cardioprotective activities [32].
Dyslipidemia and hyperglycemia are significant and in-
dependent risk factors of cardio vascular disease. Ethanol-
sucrose-treated rats showed a significant decreased of
HDL-cholesterol level and increased the levels of total
cholesterol, triglycerides and LDL-cholesterol as well as
atherogenic index. These findings are in agreement withresults obtained by Bilanda et al. [2] who reported that
hypercholesterolemia and dyslipidemia are associated with
the pathogenesis of hypertension induced by chronic etha-
nol and sucrose intake. Administration of the aqueous
extract dose-dependently provided a beneficial action on
rat lipid profile with regard to reduction of total choles-
terol, triglycerides and LDL-cholesterol and the increase
of HDL-cholesterol. The lipid lowering potential of the
extract may be attributed to the presence of phyto-
chemical constituents like flavonoids, saponins and tannins
[13,19,22]. Flavonoids are reported to lower LDL-choles-
terol and increase HDL-cholesterol concentrations in hy-
percholesteremic animals [33]. Saponins are reported to
inhibit pancreatic lipase activity in high fat diet fed mice
leading to greater fat excretion due to reduced intestinal
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http://www.biomedcentral.com/1472-6882/14/507absorption of dietary fats [34]. Similarly, tannins are recog-
nized for their ability to inhibit lipid absorption [35]. The
aqueous extract also markedly reduced atherogenic index
which is considered to be a better indicator of coronary
heart disease risk than individual lipoprotein concentration
[36]. Moreover, the extract prevented the increase in the
serum glucose level induced by chronic ethanol and su-
crose feeding suggesting its hypoglycaemic activity. The
improvement of blood glucose level induced by the aque-
ous extract was associated with a reduction of serum tri-
glycerides and total cholesterol as previously mentioned
for most hypoglycaemic treatments [37]. The glucose low-
ering effect of the extract may be due to its ability to im-
prove the function of pancreatic β cells by increasing cells
sensitivity to insulin and/or the rate of glucose transport
and utilization [14].
The present investigation revealed that chronic etha-
nol and sucrose consumption produced significant in-
crease in ALT and AST activities, two enzymes reported
to be sensitive indicator of liver injury [38]. Generally,
any damage of the parenchymal liver cells results in
elevation of both transaminases in the blood and AST
found in the serum is of both mitochondrial and cyto-
plasmic origin and any rise can be taken as a first sign of
cell damage that leads to the outflow of the enzymes
into the serum [39]. Increased in serum transaminases
in the present study was also accompanied by the eleva-
tion in serum total protein and histological abnormalities
such as vascular congestion, sinusoid dilatation and in-
flammation in the liver of ethanol-sucrose hypertensive
rats. Furthermore, we also observed an increase in the
serum creatinin content in groups treated with etha-
nol and/or sucrose when compared with normal control
group. Indeed, the serum creatinin levels is known as a
reliable and sensitive indicator of renal function and any
rise in this biochemical parameter is observed if there is
marked damage to functional nephrons [40]. In animals
simultaneously treated with ethanol and sucrose, it has
been also observed a significant increase in serum Na+
and K+. This result is in agreement with previous studies
of Kang et al. [32] who showed that hypernatremia and
hyperkalemia were associated with the pathogenesis of
fructose induced hypertension in rats. The increase in
these biochemical markers of renal function in ethanol-
sucrose hypertensive group was confirmed by histological
analysis which revealed tubular clarification. Treatment
with the aqueous extract reversed the increase of those
biochemical indicators and histological changes induced
by ethanol and sucrose intoxication in the liver and the
kidney. This potential activity of the extract might be
owing to the presence of secondary metabolites such as
flavonoids, polyphenols and alkaloids [41].
The present investigation showed that ethanol and
sucrose feeding reduced SOD and catalase activities aswell as the GSH content. Decreased activity of superoxide
dismutase in chronic ethanol and sucrose exposure may
be due to excessive generation of superoxide anion leading
to the inactivation of this enzyme meanwhile, de-
clined activity of catalase may be due to the loss of
NADPH, generation of superoxide, increased activity of
lipid peroxidation or combination of all [42]. A major
function of GSH is detoxification of xenobiotics and/or
their metabolites. The depletion of GSH content in etha-
nol and sucrose-treated rats may be due to its oxidation
by the reactive oxygen intermediates generated during the
metabolism of ethanol and inhibition of the metabolic
synthesis and increased rates of turnover [43]. Our study
has shown that SOD and catalase activities as well as the
GSH content were restored following the extract adminis-
tration, suggesting that the efficacy of this extract may be
partially attributed to its capacity to improve oxidative sta-
tus. Malondialdehyde (MDA) is one of the end-products
of polyunsaturated fatty acid peroxidation and is a good
indicator of the degree of lipid peroxidation [44]. Our re-
sults indicated increase in MDA level in the homogenates
tissues of ethanol and/or sucrose-fed animals, suggesting
enhanced lipid peroxidation leading to tissue damage and
failure of antioxidant defence mechanisms to prevent the
formation of excessive free radicals [38]. The reduced
MDA content upon administration of the extract point
out the favourable impact of this extract in breaking the
chain reaction of lipid peroxidation engendered by chronic
ethanol and sucrose ingestion. Indeed, the different plants
and honey used to prepare our aqueous extract are repor-
ted to contain various bioactive compounds such as flavo-
noids, alkaloids, tannin and polyphenols which are known
for their antioxidant activities. These compounds are able
to capture free radicals and thus protect the cell membrane
or cell integrity [32,45,46].
The vasorelaxant function of the endothelium is in
great part mediated by the production of nitric oxide
(NO). Current findings showed that the nitrites content
significantly decreased in investigated tissues of rats
treated with ethanol and sucrose compared to their nor-
mal control. The above result may be due to unfavourable
outcome of superoxide anion generated during ethanol
and sucrose feeding which can avidly reduce nitric oxide
by transferring its extra electron to NO in order to form
peroxynitrite, a potent oxidant which can antagonize the
vasodilatory effects of NO [47]. Treatment with the aque-
ous extract reversed the adverse effect of prolonged etha-
nol and sucrose intake on nitrites content suggesting its
ability to improve the endothelial function in this animal
model of secondary hypertension. This potential may be
due to the presence of secondary metabolites like flavon-
oid, alkaloids and phenols which are able to stimulate the
production of nitric oxide and to scavenge superoxide
anion [48].
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In conclusion, this study demonstrates the potential of
the aqueous extract prepared by mixing the fresh leaf of
Persea americana, stems and fresh leaf of Cymbopogon
citratus, fruits of Citrus medica and honey to prevent
ethanol and sucrose-induced hypertension in rats. More-
over, the extract improved biochemical parameters of
lipids profile, liver and kidney functions as well as oxida-
tive status. Thus, this study provides scientific validation
of the empirical use of this medicine in the management
of hypertension and could serve as a basis of the formu-
lation of improved traditional drug for hypertension.
However, more study need to be carried out in order to
determine the exact mechanism of action of our extract.
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